Skip to main content
SpringerLink
Log in

Establishment of an NOD/SCID Mouse Model for Ewing Tumors: A Potential Preclinical Model to Test Novel Purging Strategies

  • Chapter
Transplantation in Hematology and Oncology

Abstract

A quantity of 1 – 5 × 106 cells from the Ewing tumor cell lines VH-64, WE-68 and CADO-ESi were transplanted via tail vein injection into immune-deficient NOD/SCID mice. VH-64, WE-68 and CADO-ES1 cells after intravenous injection caused macroscopic disease in transplanted mice. Highly engrafted mice developed lung, bone, kidney and ovary metastases and a diffuse infiltration of the bone marrow. By RT-PCR the EWS/FLII and EWS/ERG transcripts characteristic for the transplanted cell lines could be detected in the tumors and the bone marrow of the mice. These results indicate that human Ewing tumor cells are able to home and proliferate in immune-deficient NOD/SCID mice in a fashion similar to that seen in patients. As normal hematopoietic cells and Ewing tumor cells can be co-transplanted, this model may be useful as a preclinical purging model.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Atra A, Whelan JS, Calvagna V, Shankar AG, Ashley S, Shepherd V, Souhami RL, Pinkerton CR (1997) High-dose busulphan/melphalan with autologous stem cell rescue in Ewing’s sarcoma. Bone Marrow Transplant. 20: 843–6

    Article  PubMed  CAS  Google Scholar 

  2. Baersch G, Möllers T, Hötte A, Dockhorn-Dworniczak B, Rübe C, Ritter J, Jürgens H, Vormoor J (1997) Good engraftment of B-cell precursor ALL in NOD-SCID mice. Klin. Pädiatr. 209:178–185

    Article  PubMed  CAS  Google Scholar 

  3. Brenner MK, Rill DR, Moen RC, Krance RA, Mirro J, Anderson WF, Ihle JN (1993) Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 341:85–86

    Article  PubMed  CAS  Google Scholar 

  4. Burdach S, Jürgens H, Peters C, Nürnberger W, Mauz-Körholz C, Körholz D, Paulussen M, Pape H, Dilloo D, Koscielniak E (1993) Myeloablative radio chemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing’s sarcoma. J. Clin. Oncol. 11:1482–1488

    PubMed  CAS  Google Scholar 

  5. Delattre O, Zucman J, Melot T, Garau XS, Zucker JM, Lenoir GM, Ambros PF, Sheer D, Turc-Carel C, Triche TJ, Aurias A, Gilless T (1994) The Ewing family of tumors — a subgroup of small-round-cell tumors defined by specific chimeric transscript. N. Engl. J. Med. 331:325–327

    Article  Google Scholar 

  6. Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, Kovar H, Joubert I, de-Jong P, Rouleau G, Aurias A, Thomas G (1992) Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359:162–165

    Article  PubMed  CAS  Google Scholar 

  7. Dockhorn-Dworniczak B, Schäfer KL, Dantcheva R, Blasius S, Winkelmann W, Burdach S, van Valen F, Jürgens H, Böcker W (1994) Diagnostic value of the molecular genetic detection of the 11522 translocation in Ewing’s tumours. Virchows Archiv 424:107–112

    Article  Google Scholar 

  8. Rill DR, Santana VM, Roberts WM, Nilson T, Bowman LC, Krance RA, Heslop HE, Moen RC, Ihle JN, Brenner MK (1994) Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 84:380–383

    PubMed  CAS  Google Scholar 

  9. Shultz LD, Schweitzer P, Christianson S, Gott B, Birdsall-Maller I, Tennent B, McKenna S, Mobraten L, Raj an T, Greiner D, Leiter E (1995) Multiple defects in innate and adaptive immunological function in NOD/LtSz-scid mice. J. Immunol 154:180–191

    PubMed  CAS  Google Scholar 

  10. Sirard C, Lapidot T, Vormoor J, Cashman JD, Doedens M, Murdoch B, Jamal N, Messner H, Addey L, Minden M, Laraya P, Keating A, Eaves A, Lansdorp PM, Eaves CJ, Dick JE (1996) Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis. Blood 87:1539–1548

    PubMed  CAS  Google Scholar 

  11. Vormoor J, Ritter J, Jürgens H, Dick JE (1995) Significance of the SCID mouse models for the study of normal and leukemic human hemopoiesis and gene therapy. Onkologie 18:434–438

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatric Hematology/Oncology, University of Münster, Münster, Germany

    G. Baersch, A. Hötte, H. Jürgens & J. Vormoor

  2. Department of Pathology, University of Münster, Münster, Germany

    K. L. Schäfer & B. Dockhorn-Dworniczak

  3. Department of Radiation Oncology, University of Münster, Münster, Germany

    C. Rübe

  4. Department of Orthopedics, University of Münster, Münster, Germany

    F. van Valen

Authors
  1. G. Baersch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. L. Schäfer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Hötte
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Rübe
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F. van Valen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H. Jürgens
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. B. Dockhorn-Dworniczak
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J. Vormoor
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Internal Medicine Hematology/Oncology, University of Muenster, Albert-Schweitzer-Straße 33, 48129, Muenster, Germany

    W. E. Berdel (Prof. Dr. med.), Th. Büchner (Prof. Dr. med.), J. Kienast  & J. Van De Loo (Prof. Dr. med.) (Prof. Dr. med.),  (Prof. Dr. med.),  &  (Prof. Dr. med.)

  2. Department of Pediatrics, University of Münster, Albert-Schweitzer-Straße 33, 48129, Muenster, Germany

    H. Jürgens (Prof. Dr. med.), J. Ritter (Prof. Dr. med.) & J. Vormoor (Dr. med.) (Prof. Dr. med.),  (Prof. Dr. med.) &  (Dr. med.)

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Baersch, G. et al. (2000). Establishment of an NOD/SCID Mouse Model for Ewing Tumors: A Potential Preclinical Model to Test Novel Purging Strategies. In: Berdel, W.E., et al. Transplantation in Hematology and Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59592-9_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59592-9_20

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64041-4

  • Online ISBN: 978-3-642-59592-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation